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Abstract
A formidable challenge in neural repair in the adult central nervous system (CNS) is the long
distances that regenerating axons often need to travel in order to reconnect with their targets. Thus,
a sustained capacity for axon regeneration is critical for achieving functional restoration. Although
deletion of either Phosphatase and tensin homolog (PTEN), a negative regulator of mammalian
target of rapamycin (mTOR), or suppressor of cytokine signaling 3 (SOCS3), a negative regulator
of Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway, in adult
retinal ganglion cells (RGCs) individually promoted significant optic nerve regeneration, such
regrowth tapered off around two weeks after the crush injury1,2. Remarkably, we now find that
simultaneous deletion of both PTEN and SOCS3 enables robust and sustained axon regeneration.
We further show that PTEN and SOCS3 regulate two independent pathways that act
synergistically to promote enhanced axon regeneration. Gene expression analyses suggest that
double deletion not only results in the induction of many growth-related genes, but also allows
RGCs to maintain the expression of a repertoire of genes at the physiological level after injury.
Our results reveal concurrent activation of mTOR and STAT3 pathways as a key for sustaining
long-distance axon regeneration in adult CNS, a crucial step toward functional recovery.
During development axons reach their targets first through de novo outgrowth in embryos,
followed by “networked growth” in which axons elongate with termini tethered to their
targets. As animals increase in body size during postnatal and adolescent stages, the distance
resulted from the “networked growth” could be much longer than that traveled by the initial
de novo growth. After injury in the adult CNS, regenerating axons need to carry out de novo
growth over relatively vast distances to reach their targets. Thus, the robustness of axon
regeneration, in terms of both speed and duration of axon regrowth, is critical for making
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functional reconnections in adulthood. Approaches that have been shown to promote axon
regeneration in the adult CNS include reducing extracellular inhibitory activity and
increasing intrinsic growth ability1–9. However, the extents of axon regeneration observed in
these studies are still limited. For example, our previous studies demonstrated that the
injured optic nerve could undergo significant axon regeneration after conditional deletion of
PTEN or SOCS3 in adult RGCs, but the regrowth only occurred during the first 2 weeks
post-injury, and then subsided afterwards1,2.
To identify a strategy for promoting sustained robust axon regeneration, we assessed the
effects of deleting both PTEN and SOCS3 in adult RGCs on optic nerve regeneration.
Adeno-associated viruses (AAV)-Cre (AAV-GFP as a control) were injected into the
vitreous body of PTENf/f (10), or SOCS3f/f (11), or PTENf/f/SOCS3f/f mice to delete the floxed
genes 2 weeks prior to optic nerve injury. In addition, ciliary neurotrophic factor (CNTF)
was applied intravitreously to the SOCS3f/f or PTENf/f/SOCS3f/f mice, as this enhances axon
regeneration induced by SOCS3 deletion2.
At 2 weeks post-injury, we observed a significant increase in axon regeneration in the
double knockout group (Supplementary Fig. 1a–b). The synergistic effects of the double
deletion became even more dramatic at 4 weeks after injury (Fig. 1). At 2 mm distal to the
lesion site, deletion of both genes resulted in more than 10-fold increase in the number of
regenerating axons compared to deletion of either gene alone (Fig. 1a–d). In the double
mutants, more than 20% of the regenerating axons reached the region proximal to the optic
chiasm (Fig. 1c). Among the regenerating axons passing the chiasm, some crossed the
midline and projected to the contralateral side, while others remained ipsilateral.
Occasionally, a few axons could be seen projecting into the opposite uninjured optic nerve
(Fig. 1c). Interestingly, several regenerating axons could grow even further, reaching the
optic tract brain entry zone and in the hypothalamus, the suprachiasmatic nuclei area
(Supplementary Fig. 2).
Compared to wild type animals, all three mutant groups showed significantly increased RGC
survival after injury. At 2 weeks after injury, the survival was comparable among the three
mutant groups (Supplementary Fig. 1c). At 4 weeks after injury however, the number of
surviving RGCs declined in the PTEN or SOCS3 single mutants, while the survival rate was
maintained in the double mutants (Fig. 1e).
To mimic a clinically relevant scenario, we examined whether a delayed deletion of PTEN
and/or SOCS3 still promoted sustained optic nerve regeneration. Thus, we performed
intravitreal AAV-Cre injection immediately after optic nerve injury (Fig. 2). It takes at least
3–6 days for Cre-dependent reporter expression to be observed (Supplementary Fig. 3a). We
thus examined RGC survival and axon regeneration 3 weeks post-injury in these animals.
Despite similar survivals in all groups (Supplementary Fig. 3b–c), double and single mutants
showed significant differences in the extents of axon regeneration (Fig. 2). At 0.5 mm distal
to the lesion site, up to 20-fold more regenerating axons were seen in double mutants,
compared to individual single mutants. Thus, adult RGCs with concomitant deletion of
PTEN and SOCS3 can activate a program for sustained de novo axon growth after injury.
We next examined what mechanism(s) contribute to the synergy produced by concurrent
deletion of PTEN and SOCS3. While mTOR activation is likely to be a major mediator of
PTEN deletion1, the regeneration phenotype of SOCS3 deletion is dependent on gp130, a
shared receptor components for cytokines12,13. However, multiple down-stream effectors
have been implicated in cytokines-gp130 signaling12–15. Because of a suggested relevance
to axon regeneration16–18, we tested the specific involvement of the transcription factor
STAT3, a major target of the JAK/STAT pathway19. Upon phosphorylation-mediated
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activation, STAT3 accumulates in the nucleus to initiate transcription19. By immunostaining
with anti-phospho-STAT3, we found that phospho-STAT3 expression was rarely detectable
in intact RGCs. In wild type mice, optic nerve injury increased phospho-STAT3 levels in
RGCs, but such signals were mainly localized in the cytosol (Fig. 3a, b). In contrast,
phospho-STAT3 was evident in the nuclei of axotomized RGCs with both SOCS3 single and
SOCS3/PTEN double mutants (Fig. 3a, b), suggesting the activation of STAT3 under these
conditions.
We then evaluated the contribution of STAT3 to the axon regeneration induced by SOCS3
deletion and CNTF administration. Deletion of STAT3 had no significant effects on RGC
survival (Supplementary Fig. 4) and axon regeneration (Fig. 3c). However, double deletion
of STAT3 and SOCS3 abolished injury-induced phospho-STAT3 signal (Fig. 3a, b), RGC
survival (Supplementary Fig. 4), and axon regeneration (Fig. 3c, d) seen in SOCS3 single
mutants, suggesting that STAT3 is a critical mediator of SOCS3 regulated axon regeneration
and RGC survival.
We next examined possible interactions of the PTEN- and SOCS3-regulated pathways on
optic nerve regeneration. Similar to wild type, phospho-STAT3 expression in PTEN deleted
RGCs after injury was rarely detectable (Supplementary Fig. 5), arguing against STAT3
activation after PTEN deletion. Importantly, the extents of axon regeneration and RGC
survival were similar in the animals with PTEN single deletion and PTEN/STAT3 or PTEN/
gp130 double deletion (Fig. 4a, c and Supplementary Fig. 6a, b), suggesting that STAT3 is
unlikely to be an important mediator of PTEN deletion.
We also evaluated the potential role of mTOR activation in axon regeneration induced by
SOCS3 deletion. While systematic administration of rapamycin, a specific mTOR inhibitor,
abolished the majority of the axon regeneration after PTEN deletion (Fig. 4a, c), the same
treatment did not affect axon regeneration from SOCS3-deleted RGCs (Fig. 4b, d). These
results suggest that these two pathways act independently in regulating axon regeneration.
To assess possible gene expression alteration triggered by PTEN/SOCS3 double-deletion, we
performed gene-expression profiling studies. Transgenic YFP17 mice expressing YFP in
most RGCs (with only few amacrine cells, Supplementary Fig. 7a), either in a control
background or crossed to three different mutants, were subjected to AAV-Cre injection and
optic nerve injury. 3-days post injury, mRNAs were extracted from FACS-sorted RGCs and
analyzed by microarray (Supplementary Fig. 7b–e).
The first potential mechanism is that certain key regeneration-promoting genes are
significantly altered by PTEN/SOCS3 double deletion, when compared to both single
deletions and the wild type controls. Among 15 genes selected, two encode critical positive
mTOR regulators, namely small GTPase Rheb and Insulin-like growth factor 1 (IGF1)20
(Supplementary Fig. 8, 11), suggesting that positive feedback regulation of the mTOR
activity in the double mutant may contribute to the enhanced and sustained axon
regeneration. The list also includes several axon growth-related genes, such as the RNA-
binding protein Elavl4 (HuD), the cell adhesion molecules MAM domain-containing
glycosylphosphatidylinositol anchor 2 (Mdga2)21, procadherin beta 9 (Pcdhb9)22, the axon
guidance molecule Unc5D23, and a cAMP-regulator phosphodiesterase 7B (Pde7b)24
(Supplementary Fig. 8, 11).
In addition, double deletion may “enhance” the regeneration-related gene-expression
changes that occur poorly or moderately in the single mutants. By the criteria of significant
changes (q>0.05, fold change<1.6) for comparisons between the double mutants and wild
type controls, but not between the single mutants and wild type controls, we revealed the
gene set shown in Supplementary Fig. S9a. This includes most of genes shown in
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Supplementary Fig. 8. Further, it shows the up-regulation of a number of axon growth-
related genes, such as the signaling molecule mitogen-activated protein kinase kinase
(Map2k4)25 and the axon transport components dynein component Dync1li2, kinesin family
member Kif21a, and kinesin-associated protein 3 (Kifap3)26,27 (Supplementary Fig. 9a, 11).
Consistently, pathway analysis indicates that this list is enriched in genes serving cellular
functions related to axon growth (Supplementary Fig. 9b).
Other non-exclusive possibilities may also contribute to the synergy of the double deletion.
For example, SOCS3 deletion might regulate certain axon growth-promoting genes that are
poorly regulated by PTEN single deletion, thus, double deletion allows the actions of both
mTOR activity and these genes. We therefore screened for two sets of genes preferentially
regulated by SOCS3 or PTEN deletion in the double deletion induced gene alteration
(Supplementary Fig. 10). These lists contain a number of genes related to axon regeneration,
but whether any of the above genes show complementary/synergistic functions is still
unknown. In addition, Krüppel-like factors KLF4 and KLF6 showed expression changes in
opposite directions (although the changes of KLF4 did not reach statistical significance,
Supplementary Fig. 11), consistent with proposed opposite functions of these regeneration
regulators8.
Complementarily, we assessed the expression of a subset of genes in both intact and injured
RGCs by in situ hybridization. When compared to the expression in intact RGCs, some
genes, such as Elavl4 and KLF6, were induced in the mutant(s) after injury (Supplementary
Fig. 12a, b), consistent with the model of the activation of axon growth-related genes in
these mutants. However, some other genes, such as axon transport genes Dync1li2, Kif21a,
and Kifap3, and a transcription factor ZFP40, were maintained in the double-mutant RGCs
but down-regulated in both wild type and single mutant RGCs after injury (Supplementary
Fig. 12c–f). These results suggested that in addition to inducing growth-related gene
expression, the double deletion enables injured neurons to maintain their pre-injury
physiological states, which might be an important contributing mechanism for the enhanced
and sustained axon regeneration.
Together, our experiments reveal an important strategy for achieving sustainable de novo
axon regrowth in the adult CNS neurons: co-activation of specific protein translations and
gene transcriptions by concomitant inactivation of PTEN and SOCS3. Notably, the mTOR
activity is maintained and phospho-STAT3 levels are increased in adult peripheral sensory
neurons after injury17,28. Thus, the activation states of these two pathways may underlie the
differential regenerative abilities of CNS and PNS neurons. However, deletion of PTEN and
SOCS3 is not converting the CNS neurons to a PNS-like state, because PTEN is similarly
expressed in adult PNS neurons and SOCS3 is increased during PNS regeneration17,29.
Nonetheless, enhancing mTOR activity through deletion of PTEN or TSC2 also drastically
increases axon re-growth in PNS neurons29,30, indicating deletion of PTEN and SOCS3 may
make an end-run around different growth-suppressive mechanisms. Considering the
formidable long distances that regenerating axons must travel in the adult after injury, the
synergistic effects of two different pathways suggest a potential solution to this challenge,
making the goal of functional recovery more realistic.
METHODS SUMMARY
AAV-Cre injection and optic nerve injury
Adult mice were intravitreally injected with AAV-Cre and/or CNTF to the left eyes. Optic
nerve injury and quantifications were done with the methods described previously1,2.
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72 hours after injury, isolated retinas were incubated in digestion solution, dissociated by
gentle trituration, and then filtered before FACS sorting.
RNA extraction and microarray
Isolated RNA was subjected to microarray analysis. Data were log2 transformed at probe
level, and the PM model-based expression values were annotated and normalized using
dChip. Statistical significance of gene expression differences between groups was
determined by SAM (Significance Analysis of Microarrays). After an initial filter of very
low expressed genes (average log2 transformed value <5), a False Discovery Rate (FDR
rate), or q value, less than 0.05 were used to generate the significant gene lists. Functional




All experimental procedures were performed in compliance with animal protocols approved
by the IACUC at Children’s Hospital, Boston. C57BL6/J mice (WT) or various floxed mice
including Rosa-lox-STOP-lox-Tomato (from F. Wang), SOCS3f/f, PTENf/f, SOCS3f/f/
PTENf/f, STAT3f/f, gp130f/f, SOCS3f/f/STAT3f/f, PTENf/f/STAT3f/f, PTENf/f/gp130f/f, YFP-17
crossed with or without SOCS3f/f and/or PTENf/f were intravitreally injected with 1–2 μl
volume of AAV-Cre (titers at 0.5–1.0 × 1012) to the left eyes. For each intravitreal injection,
a glass micropipette was inserted into the peripheral retina, just behind the ora serrata, and
was deliberately angled to avoid damage to the lens. In some experiments, 1 μl (1 μg/μl)
CNTF (Pepro Tech) was intravitreally injected immediately after injury and at 3 days post
injury, and weekly thereafter.
Optic nerve injury
Two weeks following AAV-Cre injection, the left optic nerve was exposed intraorbitally and
crushed with jeweler’s forceps (Dumont #5; Roboz) for 5 seconds approximately 1 mm
behind the optic disc. Counting TUJ1+ RGCs in retina whole mount and regenerating axons
were done with the methods described previously1,2.
Purification of RGCs
YFP17 mice, either themselves or crossed with PTEN and/or SOCS3 floxed mice, were
subjected to AAV-Cre injection and optic nerve injury. 72 hours post injury, animals were
euthanized and retinas were immediately dissected out for dissociation. Retinas were
incubated in digestion solution (20U/ml papain, Worthington; 1 mM L-cysteine HCL;
0.004% DNase; 0.5 mM EDTA in Neurobasal) for 30 min at 37°C, and then moved into
Ovomucoid/BSA (1 mg/ml) solution to stop digestion. Subsequently, retinas were
dissociated by gentle trituration with trituration buffer (0.5% B27; 0.004% DNase; 0.5 mM
EDTA in Opti-MEM), and then filtered through 40um cell strainer (BD Falcon) before
FACS sorting.
FACS sorting was performed with BD FACSAria IIu. Each time immediately before
sorting, a purity test was performed to insure the specificity for sorting YFP signal is higher
than 99%. Dissociated retinal cells were separated based on both size (forward scatter) and
surface characteristics (side scatter). Aggregated cells were excluded based on FSC-H vs
FSC-A ratio. Retinal cells without YFP expression was used as negative controls to set up
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the detection gate each time before sorting the YFP positive cells. Sorted cells were
immediately performed with RNA extraction.
RNA extraction and microarray
RNA was extracted using the Qiagen RNeasy mini kit (Qiagen), and RNA quality was
assessed using a bioanalyzer (Agilent Technologies). For microarray assays, RNA was
amplified and labeled with the Nugen Ovation WTA System (Nugen), to obtain 2.8 μg of
cRNA to be hybridized on Affymetrix mouse Genechip 1.0 ST (Affymetrix). To ensure
reproducibility and biological significance, three hybridizations were performed for each
group, with RNA samples collected from three independent FACS purifications, each
including three or four animals (biological replicates).
Data from microarrays were log2 transformed at probe level, and the PM model-based
expression values were annotated and normalized using dChip (www.dchip.org
<http://www.dchip.org/>). Statistical significance of gene expression differences between
groups was determined by SAM (Significance Analysis of Microarrays) software
(http://www-stat.stanford.edu/~tibs/SAM/). After an initial filter of very low expressed
genes (average log2 transformed value <5), a False Discovery Rate (FDR rate), or q value,
less than 0.05 were used to generate the significant gene lists.
Functional annotation clustering analysis was performed using DAVID (The Database for
Annotation, Visualization and Integrated Discovery, http://david.abcc.ncifcrf.gov/). The
functional annotation groups with similar EASE score, the Fish Exact Probability Value,
were clustered and grouped under the same overall enrichment score. The higher of the
score, the more enriched. The five top-scored clusters were listed, and the count of genes
and their percentage to corresponding categories in the database were shown.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Synergistic effects of double deletion of PTEN and SOCS3 on axon regeneration
observed at 4 weeks after injury
(a) Images of the optic nerve sections showing CTB-labeled axons in AAV-Cre-injected
SOCS3f/f with CNTF (SOCS3−/−), PTENf/f (PTEN−/−), or PTENf/f/SOCS3f/f with CNTF
(PTEN−/−/SOCS3−/−) mice. Asterisks: lesion sites. (b) High-magnification images of the
boxed area in (a), which is about 1.5–2.0 mm from the lesion sites. (c) Regenerating axons
at the optic chiasm. (d) Estimated numbers of regenerating axons. There was a significant
difference between PTEN−/−/SOCS3−/− group and others. *: p<0.001, ANOVA,
Bonferroni’s post hoc test. (e) Percentages of TUJ1-positive RGCs in each group compared
to that in the intact retinas. *: p<0.001, ANOVA, Tukey’s post hoc test. N=7–8 per group.
Error bars, s.d. Scale bars: 200 μm.
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Figure 2. Synergistic effects of double deletion of PTEN and SOCS3 on optic nerve regeneration
in a delayed treatment paradigm
(a) Scheme of the experiment. (b) Images of the optic nerve sections showing CTB-labeled
axons in AAV-Cre-injected SOCS3f/f with CNTF (SOCS3−/−), PTENf/f (PTEN−/−), or
PTENf/f/SOCS3f/f with CNTF (PTEN−/−/SOCS3−/−) mice. Asterisks: lesion sites. (c)
Extensive axon regeneration is only evident in double mutants. Top panel shows the entire
optic nerve up to the chiasm. Bottom panels show high-magnified areas (a and b) as
indicated in the top panel. OX: optic chiasm. (d) Estimated numbers of regenerating axons.
At all distances quantified, there was a significant difference between the PTEN−/−/
SOCS3−/− group and the remaining groups. *: p<0.001, ANOVA, Bonferroni’s post hoc
test. N=5–6 per group. Error bars, s.d. Scale bars: 100 μm.
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Figure 3. STAT3 in axon regeneration induced by SOCS3 deletion
(a) Images showing signals detected with TUJ1 or anti-p-STAT3 antibodies in the retinal
sections from intact or 1-day-post-injury mice. (b) Percentage of RGCs with nuclear
phospho-STAT3 signals. N=3–4 per group. *: p<0.001, ANOVA, Dunnett’s post hoc test.
(c, d) Images (c) and quantification (d) of optic nerve sections showing regenerating axons
in each group at 14 days post-injury. By Bonferroni’s post hoc test, regenerating axons in
SOCS3−/−/STAT3−/− double mutants were significantly less than those in the SOCS3−/−
mutants at 0.2–2.0 mm from lesion site (p<0.01; N=5 per group). Error bars, s.d. Scale bars:
50 μm in (a), 100 μm in (c).
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Figure 4. Independence of PTEN- and SOCS3- regulated pathways
(a, b) Images of optic nerve sections from PTEN−/− and various PTEN−/− combined groups
(a) or SOCS3−/− mutants with or without rapamycin treatment (b) at 14 days post-injury. (c,
d) Quantification of regenerating axons shown in (a) and (b) respectively. (c) Axon
regeneration in either PTEN−/−/gp130−/− or PTEN−/−/STAT3−/− group was comparable to
that in PTEN−/−, but was significantly reduced in the PTEN−/− group with rapamycin
(p<0.01, ANOVA, Bonferroni’s post hoc test; N=5 per group). (d) Rapamycin treatment did
not significantly reduce the number of regenerating axons in SOCS3−/− mice (N=6 per
group). Error bars, s.d. Scale bars: 100 μm.
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